Atlas market file · Etf · United States
Applied Finance IVS International SMID ETFIVSX
- Last close
- 25.6824
- Change
- +0.17%
- 96-bar range
- 22.47 – 26.2
- As of
- 11 Aug 2026
Applied Finance IVS International SMID ETF is an exchange-traded fund listed as IVSX on NASDAQ. Use this page to check the price chart, company context, source-backed updates, risks and evidence before opening the full Atlas research file.
- Identity
- Nasdaq Trader
- Chart rail
- TradingView
- File state
- Public profile
Static Daily candlestick snapshot from the approved cache, drawn on a labelled price axis: green bodies closed up, red closed down, wicks span each bar's high-to-low range. The live TradingView link stays available; the public profile never embeds a widget that can render the wrong symbol.
▮ up candle ▮ down candle
Weekly outlook: the last 27 weekly closes (+1.55% over the window).
Source rail: Yahoo Finance chart API (IVSX). This dated snapshot is the crawlable Atlas reference.
Live market viewTradingView · provider feed Open view ->
Open the attributed TradingView market view for IVSX. The dated Atlas snapshot above remains the crawlable reference; exchange data in this panel may be live or delayed as labelled by TradingView.
IVSX public profile
Exchange-traded fund. Applied Finance IVS International SMID ETF is connected to current market context, cited company sources and its retained research file.
Applied Finance IVS International SMID ETF trades as IVSX on NASDAQ. Applied Finance IVS International SMID ETF (IVSX) has a latest verified close of 25.6824, up 0.17%, dated 11 Aug 2026.
Open the chart, inspect attributed company evidence and continue into the fuller research file without losing this market context. IVSX stays in the main symbols index until Atlas has enough listing or name evidence for a narrower browse group.
What changed for Applied Finance IVS International SMID ETF today
IVSX, the Applied Finance IVS International SMID ETF, is a wrapper designed to capture the supposed dynamism of small and mid-cap stocks across developed and emerging international markets. The Nasdaq listing confirms the fund trades under the ticker IVSX, but the page reveals no volume, spread, or depth data to suggest robust liquidity. Instead, it offers the usual ETF marketing page: a promise of global growth, a splash of thematic colour, and a fee that quietly chips away at returns year after year. (source: Nasdaq, https://www.nasdaq.com/market-activity/etf/ivsx)
The fund’s existence is confirmed by SEC EDGAR, but the filing is a skeletal affair: it lists the wrapper’s identity, structure, and domicile, yet contains no disclosure of holdings, performance, or the ‘international SMID’ story it sells. The ETF is a theme in search of evidence, a label pinned to a fee and a ticker. (source: SEC EDGAR, https://www.sec.gov/edgar/search/#/q=IVSX)
The FINRA Fund Analyzer steps in to quantify the cost: an expense ratio of 0.50% is etched into the fund’s operating model. The Analyzer confirms the fee is real, the wrapper is real, and the liquidity is whatever the market decides to offer. But it stops short of telling investors what the fund owns, how those holdings perform, or whether the ‘international SMID’ pitch survives contact with reality. The data is precise but incomplete: a fee is a fee, a fund is a fund, and a label is just a label until the holdings prove otherwise. (source: FINRA Fund Analyzer, https://tools.finra.org/fund_analyzer/)
The Nasdaq page for IVSX does not provide a chart route or liquidity depth, so any attempt to analyse trading patterns or levels would be speculation. The fund’s market behaviour remains a black box: you can see it listed, you can see it listed, but you cannot see its inner workings without diving into the holdings, which are not disclosed in the sourced evidence. Until those details emerge, IVSX trades as a thematic wrapper with a fee and a ticker, not as a transparent investment vehicle. (source: Nasdaq, https://www.nasdaq.com/market-activity/etf/ivsx)
What changed today? Nothing in the sourced evidence suggests a material update to IVSX’s holdings, fees, or trading characteristics. The fund continues to trade as a listed ETF with a 0.50% expense ratio, confirmed by FINRA’s Fund Analyzer, and its SEC EDGAR entry remains unchanged. The gap between the marketing promise and the disclosed reality persists, and investors are left to trust the theme rather than the tick data. (source: SEC EDGAR, https://www.sec.gov/edgar/search/#/q=IVSX; FINRA Fund Analyzer, https://tools.finra.org/fund_analyzer/)
Sources & evidence · 3 links
This is the public answer layer. The full Atlas report adds the complete Market Wit archive, risk rail, catalyst map, final editor synthesis, PDF/CSV export, email delivery and saved history.
IVSX technical readout
Directional bias up. Wilder ADX and ATR computed from Atlas approved daily OHLC through 2026-07-28. Indicators are descriptive statistics, not investment advice.
Open an Atlas research path on IVSX
FreedomCore Atlas can expand this public profile into source-led research files with holdings and concentration, index methodology, exposure and overlap, fees and tracking difference, and liquidity context. Each path keeps the underlying public sources visible.
Open Atlas workstation ->Keep IVSX research in your Atlas archive
Free Atlas includes the public profile and one owned welcome research artifact after account setup. Atlas Pro adds up to 25 custom research runs a day, a 500-symbol watchlist, saved report versions, and eligible PDF, CSV, and email artifacts. Evidence holds still apply and never become an unverified download. £12/month founding price, locked for life. Research only; not investment advice.
Checking Atlas access...
IVSX FAQ
What is Applied Finance IVS International SMID ETF (IVSX)?Applied Finance IVS International SMID ETF (IVSX) has a latest verified close of 25.6824, up 0.17%, dated 11 Aug 2026. Use this page to check the price chart, company...
Applied Finance IVS International SMID ETF (IVSX) has a latest verified close of 25.6824, up 0.17%, dated 11 Aug 2026. Use this page to check the price chart, company context, source-backed updates, risks and evidence before opening the full Atlas research file.
What does Atlas show for IVSX?Applied Finance IVS International SMID ETF (IVSX) has a latest verified close of 25.6824, up 0.17%, dated 11 Aug 2026. It brings the latest available chart, company...
Applied Finance IVS International SMID ETF (IVSX) has a latest verified close of 25.6824, up 0.17%, dated 11 Aug 2026. It brings the latest available chart, company context, cited sources, risks and the route into the full Atlas research file together. IVSX stays in the main symbols index until Atlas has enough listing or name evidence for a narrower browse group.
How often is the IVSX page updated?The IVSX public file is refreshed when a newer verified market bar, company filing, official release or material source update is available. The visible date shows the...
The IVSX public file is refreshed when a newer verified market bar, company filing, official release or material source update is available. The visible date shows the freshness of the current market snapshot.
Which sources does Atlas use for IVSX?The IVSX file starts with Nasdaq Trader and TradingView NASDAQ:IVSX. The page separates verified market context from company evidence and shows open evidence gaps...
The IVSX file starts with Nasdaq Trader and TradingView NASDAQ:IVSX. The page separates verified market context from company evidence and shows open evidence gaps instead of filling them with assumptions.
Can Atlas run a full research brief on IVSX?Yes. The workstation can open IVSX, expand the public source set into a fuller browser report, and add email, PDF or CSV export where the account tier allows it.
Yes. The workstation can open IVSX, expand the public source set into a fuller browser report, and add email, PDF or CSV export where the account tier allows it.
Is this IVSX page investment advice?No. The IVSX page is a research and source-navigation page. It does not provide personalised financial advice, brokerage execution, a trading instruction, or a promise...
No. The IVSX page is a research and source-navigation page. It does not provide personalised financial advice, brokerage execution, a trading instruction, or a promise of returns.
Methodology
This profile is generated daily from public sources including SEC EDGAR (US-listed companies), NASDAQ Trader files, exchange listings, public macro/central-bank releases, CoinGecko crypto market files where relevant, and the TradingView global symbol catalog. Multi-model AI may assist drafting and review where configured, but sources remain the evidence rail; the chart is an Atlas static OHLC rail with a live TradingView link when verified bars are available; otherwise the page keeps the verified TradingView route as an explicit fallback.
Research only. Not investment advice. No brokerage execution. No guaranteed returns are promised or implied. FreedomCore does not provide personalised investment advice. Always consult a regulated financial advisor before making investment decisions.
Profile last updated: 2026-08-07. Browse FreedomCore Atlas research notes →
IVSX
Etf · evidence first